Company page

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H, trading under the ticker 2566 on the Hong Kong market, has a market capitalization of approximately HKD 184.54 million. The company focuses on the development and production of genetic biopharmaceuticals. Its innovative approach aims to address various health challenges through advanced biotechnology solutions.